NYSE - Delayed Quote USD

Nevro Corp. (NVRO)

12.07 -0.25 (-2.03%)
At close: April 19 at 4:00 PM EDT
12.31 +0.24 (+1.99%)
After hours: April 19 at 5:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
425,174.00
425,174.00
406,365.00
386,905.00
362,048.00
Cost of Revenue
135,114.00
135,114.00
129,998.00
120,863.00
112,146.00
Gross Profit
290,060.00
290,060.00
276,367.00
266,042.00
249,902.00
Operating Expense
389,368.00
389,368.00
375,203.00
356,976.00
312,754.00
Operating Income
-99,308.00
-99,308.00
-98,836.00
-90,934.00
-62,852.00
Net Non Operating Interest Income Expense
6,152.00
6,152.00
-2,411.00
-19,078.00
-18,850.00
Other Income Expense
-4,703.00
-4,703.00
105,511.00
-20,814.00
-495.00
Pretax Income
-97,859.00
-97,859.00
4,264.00
-130,826.00
-82,197.00
Tax Provision
-5,646.00
-5,646.00
1,263.00
534.00
868.00
Net Income Common Stockholders
-92,213.00
-92,213.00
3,001.00
-131,360.00
-83,065.00
Diluted NI Available to Com Stockholders
-92,213.00
-92,213.00
3,001.00
-131,360.00
-83,065.00
Basic EPS
-2.56
--
0.08
-3.77
-2.47
Diluted EPS
-2.56
--
0.08
-3.77
-2.47
Basic Average Shares
35,981.43
--
35,317.64
34,823.26
33,677.64
Diluted Average Shares
35,981.43
--
35,525.26
34,823.26
33,677.64
Total Operating Income as Reported
-99,308.00
-99,308.00
6,164.00
-110,934.00
-62,852.00
Total Expenses
524,482.00
524,482.00
505,201.00
477,839.00
424,900.00
Net Income from Continuing & Discontinued Operation
-92,213.00
-92,213.00
3,001.00
-131,360.00
-83,065.00
Normalized Income
-88,330.67
-88,330.67
-70,919.00
-116,760.00
-83,065.00
Interest Income
14,166.00
14,166.00
4,021.00
671.00
2,956.00
Interest Expense
8,014.00
8,014.00
6,432.00
19,749.00
21,806.00
Net Interest Income
6,152.00
6,152.00
-2,411.00
-19,078.00
-18,850.00
EBIT
-89,845.00
-89,845.00
10,696.00
-111,077.00
-60,391.00
EBITDA
-78,310.00
-78,310.00
21,023.00
-102,399.00
-52,205.00
Reconciled Cost of Revenue
123,825.00
123,825.00
119,671.00
112,185.00
112,146.00
Reconciled Depreciation
11,535.00
11,535.00
10,327.00
8,678.00
8,186.00
Net Income from Continuing Operation Net Minority Interest
-92,213.00
-92,213.00
3,001.00
-131,360.00
-83,065.00
Total Unusual Items Excluding Goodwill
-4,117.00
-4,117.00
105,000.00
-20,000.00
--
Total Unusual Items
-4,117.00
-4,117.00
105,000.00
-20,000.00
--
Normalized EBITDA
-74,193.00
-74,193.00
-83,977.00
-82,399.00
-52,205.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-234.67
-234.67
31,080.00
-5,400.00
--
12/31/2020 - 11/6/2014
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

LIVN LivaNova PLC
52.33
-0.82%
 
CNMD CONMED Corporation
72.64
+2.19%
 
NPCE NeuroPace, Inc.
13.98
-0.14%
 
SIBN SI-BONE, Inc.
15.42
+0.78%
 
OFIX Orthofix Medical Inc.
13.10
+0.61%
 
IART Integra LifeSciences Holdings Corporation
28.68
-9.33%
 
PEN Penumbra, Inc.
202.72
+0.44%
 
INGN Inogen, Inc.
6.75
-4.80%
 
VREX Varex Imaging Corporation
16.99
+0.41%
 
AVNS Avanos Medical, Inc.
18.71
+0.05%